The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
The IGNITE network: a model for genomic medicine implementation and research
Open accessAbstract
BACKGROUND: Patients, clinicians, researchers and payers are seeking to understand the value of using genomic information (as reflected by genotyping, sequencing, family history or other data) to inform clinical decision-making. However, challenges exist to widespread clinical implementation of genomic medicine, a prerequisite for developing evidence of its real-world utility. METHODS: To address these challenges, the National Institutes of Health-funded IGNITE (Implementing GeNomics In pracTicE; www.ignite-genomics.org ) Network, comprised of six projects and a coordinating center, was established in 2013 to support the development, investigation and dissemination of genomic medicine practice models that seamlessly integrate genomic data into the electronic health record and that deploy tools for point of care decision making. IGNITE site projects are aligned in their purpose of testing these models, but individual projects vary in scope and design, including exploring genetic markers for disease risk prediction and prevention, developing tools for using family history data, incorporating pharmacogenomic data into clinical care, refining disease diagnosis using sequence-based mutation discovery, and creating novel educational approaches. RESULTS: This paper describes the IGNITE Network and member projects, including network structure, collaborative initiatives, clinical decision support strategies, methods for return of genomic test results, and educational initiatives for patients and providers. Clinical and outcomes data from individual sites and network-wide projects are anticipated to begin being published over the next few years. CONCLUSIONS: The IGNITE Network is an innovative series of projects and pilot demonstrations aiming to enhance translation of validated actionable genomic information into clinical settings and develop and use measures of outcome in response to genome-based clinical interventions using a pragmatic framework to provide early data and proofs of concept on the utility of these interventions. Through these efforts and collaboration with other stakeholders, IGNITE is poised to have a significant impact on the acceleration of genomic information into medical practice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Damschroder, L. J., Aron, D. C., Keith, R. E., Kirsh, S. R., Alexander, J. A., & Lowery, J. C. (2009) · Implementation Science · doi:10.1186/1748-5908-4-50 · Cited by 14,496
(2) Classification and diagnosis of diabetes
American Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc15-s005 · Cited by 1,841
Su, Z., Dias-Santagata, D., Duke, M., Hutchinson, K., Lin, Y.-L., Borger, D. R., Chung, C. H., Massion, P. P., Vnencak-Jones, C. L., Iafrate, A. J., et al. (2011) · The Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2010.11.010 · Cited by 176 · cited 1×
“The Personalized Cancer Medicine Initiative (PCMI) provides routine, multiplexed tumor gene mutation testing for patients with various cancer diagnoses, including non-small cell lung cancer (NSCLC) and melanoma.[12, 13] The Pharmacogenomic Resource for Enhanced Decisions In Care and Treatment (PREDICT) program provide…”
Method
Cited by
Enabling Technologies for Personalized and Precision Medicine
Ho, D., Quake, S. R., McCabe, E. R. B., Chng, W. J., Chow, E. K., Ding, X., Gelb, B. D., Ginsburg, G. S., Hassenstab, J., Ho, C.-M., et al. (2020) · Trends in Biotechnology · doi:10.1016/j.tibtech.2019.12.021 · Cited by 517
Self-citationFrom Big Data to Precision Medicine
Hulsen, T., Jamuar, S. S., Moody, A. R., Karnes, J. H., Varga, O., Hedensted, S., Spreafico, R., Hafler, D. A., & McKinney, E. F. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00034 · Cited by 459
Personalized Medicine and the Power of Electronic Health Records
Abul-Husn, N. S., & Kenny, E. E. (2019) · Cell · doi:10.1016/j.cell.2019.02.039 · Cited by 355
Prioritizing diversity in human genomics research
Hindorff, L. A., Bonham, V. L., Brody, L. C., Ginoza, M. E. C., Hutter, C. M., Manolio, T. A., & Green, E. D. (2018) · Nature Reviews Genetics · doi:10.1038/nrg.2017.89 · Cited by 386
Self-citationvan der Wouden, C., Cambon‐Thomsen, A., Cecchin, E., Cheung, K., Dávila‐Fajardo, C., Deneer, V., Dolžan, V, Ingelman‐Sundberg, M., Jönsson, S., Karlsson, M., et al. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.602 · Cited by 306
Metadata
- Authors
- on behalf of the IGNITE Network, Weitzel, K. W., Alexander, M., Bernhardt, B. A., Calman, N., Carey, D. J., Cavallari, L. H., Field, J. R., Hauser, D., Junkins, H. A., Levin, P. A., Levy, K., Madden, E. B., Manolio, T. A., Odgis, J., Orlando, L. A., Pyeritz, R., Wu, R. R., Shuldiner, A. R., Bottinger, E. P., Denny, J. C., Dexter, P. R., Flockhart, D. A., Horowitz, C. R., Johnson, J. A., Kimmel, S. E., Levy, M. A., Pollin, T. I., & Ginsburg, G. S.
- Venue
- BMC Medical Genomics
- Published
- 2015-12
- Volume
- 9
- Issue
- 1
- Pages
- 1-1
- ISSN
- 1755-8794 (ISSN-L)
- OpenAlex
- W2226311111
- Cited by
- 246
- References
- 3
- FWCI
- 18.50
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The IGNITE network: a model for genomic medicine implementation and research. https://app.cochat.ai/papers/10.1186/s12920-015-0162-5
- The paper
- on behalf of the IGNITE Network, Weitzel, K. W., Alexander, M., Bernhardt, B. A., Calman, N., Carey, D. J., Cavallari, L. H., Field, J. R., Hauser, D., Junkins, H. A., Levin, P. A., Levy, K., Madden, E. B., Manolio, T. A., Odgis, J., Orlando, L. A., Pyeritz, R., Wu, R. R., Shuldiner, A. R., . . . Ginsburg, G. S. (2015). The IGNITE network: a model for genomic medicine implementation and research. BMC Medical Genomics. https://doi.org/10.1186/s12920-015-0162-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.